Literature DB >> 7884847

Characterization of an infectious molecular clone of human T-cell leukemia virus type I.

T M Zhao1, M A Robinson, F S Bowers, T J Kindt.   

Abstract

An infectious molecular clone of human T-cell leukemia virus type I (HTLV-I) was derived from an HTLV-I-transformed rabbit T-cell line, RH/K30, obtained by coculture of rabbit peripheral blood mononuclear cells (PBMC) with the human HTLV-I-transformed cell line MT-2. The RH/K30 cell line contained two integrated proviruses, an intact HTLV-I genome and an apparently defective provirus with an in-frame stop codon in the env gene. A genomic DNA fragment containing the intact HTLV-I provirus was cloned into bacteriophage lambda (K30 phi) and subcloned into a plasmid vector (K30p). HTLV-I p24gag protein was detected in culture supernatants of human and rabbit T-cell and fibroblast lines transfected with these clones, at levels comparable to those of the parental cell line RH/K30. Persistent expression of virus was observed in one of these lines, RL-5/K30p, for more than 24 months. Biologic characterization of this cell line revealed the presence of integrated HTLV-I provirus, spliced and unspliced mRNA transcripts, and typical extracellular type C retrovirus particles. As expected, these virus particles contained HTLV-I RNA and reverse transcriptase activity. The transfected cells also expressed surface major histocompatibility complex class II, whereas no expression of this molecule was detected in the parental RL-5 cell line. Virus was passaged by cocultivation of irradiated RL-5/K30p cells with either rabbit PBMC or human cord blood mononuclear cells, demonstrating in vitro infectivity. The virus produced in these cells was also infectious in vivo, since rabbits injected with RL-5/K30p cells became productively infected, as evidenced by seroconversion, amplification of HTLV-I-specific sequences by PCR from PBMC DNA, and virus isolation from PBMC. Availability of infectious molecular clones will facilitate functional studies of HTLV-I genes and gene products.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7884847      PMCID: PMC188867     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Viral genetic determinants of T-cell killing and immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS.

Authors:  P R Donahue; S L Quackenbush; M V Gallo; C M deNoronha; J Overbaugh; E A Hoover; J I Mullins
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

Review 2.  Genetic and biological comparisons of pathogenic and nonpathogenic molecular clones of simian immunodeficiency virus (SIVmac).

Authors:  P A Luciw; K E Shaw; R E Unger; V Planelles; M W Stout; J E Lackner; E Pratt-Lowe; N J Leung; B Banapour; M L Marthas
Journal:  AIDS Res Hum Retroviruses       Date:  1992-03       Impact factor: 2.205

Review 3.  HIV with multiple gene deletions as a live attenuated vaccine for AIDS.

Authors:  R C Desrosiers
Journal:  AIDS Res Hum Retroviruses       Date:  1992-03       Impact factor: 2.205

4.  In vivo genomic variability of human T-cell leukemia virus type I depends more upon geography than upon pathologies.

Authors:  F Komurian; F Pelloquin; G de Thé
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

5.  Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene.

Authors:  M D Daniel; F Kirchhoff; S C Czajak; P K Sehgal; R C Desrosiers
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

6.  Multiple viral determinants contribute to pathogenicity of the acutely lethal simian immunodeficiency virus SIVsmmPBj variant.

Authors:  F J Novembre; P R Johnson; M G Lewis; D C Anderson; S Klumpp; H M McClure; V M Hirsch
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

Review 7.  An HTLV-I vaccine: why, how, for whom?

Authors:  G de Thé; R Bomford
Journal:  AIDS Res Hum Retroviruses       Date:  1993-05       Impact factor: 2.205

8.  Variation in HTLV-I sequences from rabbit cell lines with diverse in vivo effects.

Authors:  T M Zhao; M A Robinson; S Sawasdikosol; R M Simpson; T J Kindt
Journal:  Virology       Date:  1993-07       Impact factor: 3.616

9.  DNA sequence analysis of the gene encoding the HTLV-I p21e transmembrane protein reveals inter- and intraisolate genetic heterogeneity.

Authors:  G D Ehrlich; J Andrews; M P Sherman; S J Greenberg; B J Poiesz
Journal:  Virology       Date:  1992-02       Impact factor: 3.616

10.  Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: novel mRNAs and proteins produced by HTLV type I.

Authors:  V Ciminale; G N Pavlakis; D Derse; C P Cunningham; B K Felber
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

View more
  28 in total

1.  Multiplex detection of four pathogenic retroviruses using molecular beacons.

Authors:  J A Vet; A R Majithia; S A Marras; S Tyagi; S Dube; B J Poiesz; F R Kramer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

2.  Infectivity of chimeric human T-cell leukemia virus type I molecular clones assessed by naked DNA inoculation.

Authors:  T M Zhao; M A Robinson; F S Bowers; T J Kindt
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

Review 3.  Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation.

Authors:  Michael D Lairmore; Lee Silverman; Lee Ratner
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

4.  The human T-cell leukemia virus type 1 Rex regulatory protein exhibits an impaired functionality in human lymphoblastoid Jurkat T cells.

Authors:  S Hamaia; H Cassé; L Gazzolo; M Duc Dodon
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  Physical and functional interaction between the human T-cell lymphotropic virus type 1 Tax1 protein and the CCAAT binding protein NF-Y.

Authors:  C A Pise-Masison; J Dittmer; K E Clemens; J N Brady
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

6.  Human and simian T-cell leukemia viruses type 2 (HTLV-2 and STLV-2(pan-p)) transform T cells independently of Jak/STAT activation.

Authors:  J C Mulloy; T S Migone; T M Ross; N Ton; P L Green; W J Leonard; G Franchini
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

7.  Genes in the pX region of human T cell leukemia virus I influence Vav phosphorylation in T cells.

Authors:  W Mahana; T M Zhao; R Teller; M A Robinson; T J Kindt
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

8.  Cloning and expression of a human T-lymphotropic virus type 1 protein with reverse transcriptase activity.

Authors:  S M Owen; R B Lal; R A Ikeda
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

9.  Development of a novel surrogate virus for human T-cell leukemia virus type 1: inhibition of infection by osteoprotegerin.

Authors:  Kazu Okuma; Kevin P Dalton; Linda Buonocore; Elizabeth Ramsburg; John K Rose
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

10.  Characterization of New Zealand White Rabbit Gut-Associated Lymphoid Tissues and Use as Viral Oncology Animal Model.

Authors:  Robyn A Haines; Rebeccah A Urbiztondo; Rashade A H Haynes; Elaine Simpson; Stefan Niewiesk; Michael D Lairmore
Journal:  ILAR J       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.